title: Spontaneous and induced aneuploidy, considerations which may influence chromosome malsegregation.
abstract: Aneuploidy plays a major role in the production of human birth defects and is becoming increasingly recognised as a critical event in the etiology of a wide range of human cancers. Thus, the detection of aneuploidy and the characterisation of the mechanisms which lead to chromosome malsegregation is an important area of genotoxicological research. As an aid to aneuploidy research, methods have been developed to analyse the mechanisms of chromosome malsegregation and to investigate the role of aneuploidy in tumour progression. The presence of aneuploid cells is a common characteristic of many of tumour cell types as illustrated by the wide range of chromosome number changes detected in post-menopausal breast tumours. To investigate the time of occurrence of aneuploidy during tumour progression, we have studied the chromosome number status of Syrian hamster dermal (SHD) cells cultures progressing to morphological transformation. The production of both polyploid and aneuploid cells is a common feature of progressing cells in this model. The elevation of both progression to morphological transformation and aneuploid frequencies can be produced by exposure to a diverse range of carcinogens and tumour promoters. Analysis of the genotoxic activity of the hormone 17-beta oestradiol demonstrated its ability to induce both chromosome loss and non-disjunction in human lymphoblastoid cells implicating aneugenic activity in hormone related cancers. Mutations in the p53 tumour suppressor gene introduced into human fibroblasts produced modifications in chromosome separation at mitosis which may lead to the production of both aneuploidy and polyploid cells. Our studies indicate that the production of aneuploid cells can be influenced by both endogenous and exogenous factors and occur throughout the progression of normal cells to a malignant phenotype.
authors.affiliation: Centre for Molecular Genetics and Toxicology, School of Biological Sciences, University of Wales Swansea, Singleton Park, Swansea, UK. jmp@swansea.ac.uk
authors.forename: James M
authors.initials: JM
authors.lastname: Parry
authors.forename: A
authors.initials: A
authors.lastname: Al-Obaidly
authors.forename: M
authors.initials: M
authors.lastname: Al-Walhaib
authors.forename: M
authors.initials: M
authors.lastname: Kayani
authors.forename: T
authors.initials: T
authors.lastname: Nabeel
authors.forename: J
authors.initials: J
authors.lastname: Strefford
authors.forename: E M
authors.initials: EM
authors.lastname: Parry
mesh_terms: D000477:Alkylating Agents / Q000494:pharmacology; D000782:Aneuploidy; D000818:Animals; D000831:Animals, Newborn; D002461:Cell Line, Transformed; D002478:Cells, Cultured; D020090:Chromosome Segregation / Q000187:drug effects / Q000235:genetics*; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D015894:Genome, Human; D006801:Humans; D008647:Mesocricetus; D015162:Micronucleus Tests; D009154:Mutation; D009693:Nucleic Acid Hybridization / Q000379:methods; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000502:physiology
chemical_list: D000477:Alkylating Agents; D016159:Tumor Suppressor Protein p53; D004958:Estradiol